NO20083270L - Indolforbindelser - Google Patents

Indolforbindelser

Info

Publication number
NO20083270L
NO20083270L NO20083270A NO20083270A NO20083270L NO 20083270 L NO20083270 L NO 20083270L NO 20083270 A NO20083270 A NO 20083270A NO 20083270 A NO20083270 A NO 20083270A NO 20083270 L NO20083270 L NO 20083270L
Authority
NO
Norway
Prior art keywords
indole compounds
indole
compounds
Prior art date
Application number
NO20083270A
Other languages
English (en)
Inventor
Rolf Kristian Berge
Andrew David Miller
Michael R Jorgensen
Jon Skorve
Therese Rost
Yushma Bhurruth-Alcor
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Priority to NO20083270A priority Critical patent/NO20083270L/no
Priority to PCT/NO2009/000270 priority patent/WO2010011147A1/en
Publication of NO20083270L publication Critical patent/NO20083270L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20083270A 2008-07-23 2008-07-23 Indolforbindelser NO20083270L (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO20083270A NO20083270L (no) 2008-07-23 2008-07-23 Indolforbindelser
PCT/NO2009/000270 WO2010011147A1 (en) 2008-07-23 2009-07-23 Indole compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20083270A NO20083270L (no) 2008-07-23 2008-07-23 Indolforbindelser

Publications (1)

Publication Number Publication Date
NO20083270L true NO20083270L (no) 2010-01-25

Family

ID=41202538

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083270A NO20083270L (no) 2008-07-23 2008-07-23 Indolforbindelser

Country Status (2)

Country Link
NO (1) NO20083270L (no)
WO (1) WO2010011147A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012071458A1 (en) 2010-11-22 2012-05-31 Array Biopharma Inc. Heterocyclic inhibitors of beta - secretase for the treatment of neurodegenerative diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9812772A (pt) * 1997-10-27 2000-10-10 Reddy Research Foundation "compostos tricìclicos inéditos e o seu emprego na medicina;processo para a sua preparação e composições farmacêuticas contendo os mesmos"
MXPA05002704A (es) * 2002-09-12 2005-05-05 Hoffmann La Roche Compuestos de acido n-sustituido-1h-indol-5-propionico como agonistas de los receptores activados proliferadores de peroxisomas (ppar) utiles para el tratamiento de diabetes.

Also Published As

Publication number Publication date
WO2010011147A1 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
DK2288375T3 (da) Pegylerede insulin-lispro-forbindelser
BRPI0920707A2 (pt) compostos
SMT201600045B (it) Composti tetraciclinici c7-fluoro sostituiti
DK2242759T3 (da) Forbindelser
DK2340021T3 (da) Substituerede pyrrolidin-2-carboxamider
BRPI0907376A2 (pt) Fotobiorretador
DK2308877T3 (da) Imidazopyridin-2-on-derivater
BRPI0914942A2 (pt) Compostos de oxindol
BRPI0914649A2 (pt) Piprazolo-quinazolinas
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
FIC20240018I1 (fi) Vamoroloni
BRPI0906705A2 (pt) Composto heterocíclicos
DK2297162T3 (da) Forbindelser
DK2275414T3 (da) Cyclopentylacrylamidderivat
ATE545635T1 (de) Substituierte n-oxidpyrazinderivate
BRPI0916432A2 (pt) compostos
BRPI0915562A2 (pt) tamis melhorado
BRPI0915442A2 (pt) tamis melhorado
BRPI0907522A2 (pt) biarlamidas
BRPI0922098A2 (pt) composto inorgânicos
ATE534634T1 (de) 2-phenyl-4-cyclopropyl-pyrimidinderivate
BRPI0909634A2 (pt) 2-aminoquinolinas
DE112009000183A5 (de) Sicherheitsvorreiber
BRPI0923592A2 (pt) composto
DE112009001946A5 (de) Mobelauszugsführung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application